| [1] |
Nash K, Hafeez A, Hou S．Hospital-acquired renal insufficiency[J]．Am J Kidney Dis，2002，39(5):930-936.
|
| [2] |
Parfrey P．The clinical epidemiology of contrast-induced nephropathy[J]．Cardiovasc Intervent Radiol，2005，28(Suppl 2):S3-S11.
|
| [3] |
Dangas G, Iakovou I, Nikolsky E，et al.Contras-induced nephropaty after percutanetous in relation to chronic kidney disease and hemodynamic variables[J]．Am J Cardiol，2005，95(1):13-19.
|
| [4] |
Manske CL, Sprafka JM, Strony JT，et al.Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography [J]．Am J Med，1990，89(5):615-620.
|
| [5] |
De Broe ME, Porter GA, Bennett WM，et al.Clinical nephrotoxins：renal injury from drugs and chemicals[M]．Kluwer Academic Publishers，2003.
|
| [6] |
Nozue T, Michishita I, Iwaki T，et al.Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention[J]．J Cardiol，2009，54(2):214-220.
|
| [7] |
Mehran R, Nikolsky E．Contrast-induced nephropathy：definition，epidemiology，and patients at risk[J]．Kidney Int Suppl，2006，100:S11-S15.
|
| [8] |
Chong E, Poh KK, Liang S，et al.Risk fractors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine[J]．Ann Acad Med Singapore，2010，39(5):374-380.
|
| [9] |
Wang XC, Fu XH, Wang YB，et al.Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention：role of the ratio of contrast medium volume to estimated glomerular filtration rate[J]．Chin Med J (Engl)，2011，124(6):892-896.
|
| [10] |
Ma YC, Zuo L, Chen JH，et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease[J]．J Am Soc Nephrol, 2006，17(10):2937-2944.
|
| [11] |
Liistro F, Falsini G, Bolognese L．The clinical burden of contrast media-induced nephropathy [J]．Ital Heart J，2003，4(10):668-676.
|
| [12] |
张洁，赵建华，王志英，等．高龄人造影剂肾病临床相关因素及预防措施[J]．中华保健医学杂志，2009，11(4):286-288.
|
| [13] |
Mueller C, Buerkle G, Buet tner HJ，et al.Prevention of contrast media-associated nephropathy：randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty [J]．Arch Intern Med，2002，162(3):329-336.
|
| [14] |
Esplugas E, Cequier A, Gomes-Hospital JA，et al.Comparative tolerability of contrast media used for coronary interventions[J]．Drug Saf，2002，25(15):1079-1098.
|
| [15] |
Nguyen SA, Suranyi P, Ravenel JG，et al.Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous cont rast-enhanced CT：effect on kidney function[J]．Radiology，2008，248(1):97-105.
|
| [16] |
Toprak O, Cirit M, Yesil M，et al.Metabolic syndrome as a risk factor for contrast-induced nephropathy in non-diabetic elderly patients with renal impairment[J]．Kidney Blood Press Res，2006，29(1):2-9.
|
| [17] |
Zhang Pian, Ni Zhaohui, Wang Ling，et al.A Multi-center clinical study of contrast-induced nephropathy in inpatients in cardiology department after coronary artery intervention[J]．Chinese Journal of Blood Purification，2010，9(7):375-370.
|
| [18] |
Bartholomew BA, Harjai KJ, Dukkipati S，et al.Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification[J]．Am J Cardiol，2004，93(12):1515-1519.
|
| [19] |
Nikolsky E, Mehran R, Turcot D，et al.Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneouscoronary intervention[J]．Am J Cardiol, 2004，94(3):300-305.
|
| [20] |
Asif A, Preston RA, Roth D．Radiocontrast-induced nephropathy[J]．Am J Ther，2003，10(2):137-147.
|
| [21] |
Rubenstein MH, Sheynberg BV, Harrell LC，et al.Effectiveness and adverse events after percutaneous coronary intervention in patients with mild versus severe renal failure[J]．Am J Cardiol，2001，87(7):856-860.
|
| [22] |
郭敏，邹阳春．造影剂肾病研究进展[J]．中华高龄多器官疾病杂志，2010，9(3):286-288.
|
| [23] |
Abe M, Kimura T, Morimoto T，et al.Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients[J]．Circ J，2009，73(8):15l8-1522.
|
| [24] |
Freeman RV, O’Donnell M, Share D，et al.Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose[J]．Am J Cardiol，2002，90(10):1068-1073.
|
| [25] |
Sherwin PF, Cambron R, Johnson JA，et al.Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy：correlation of D/CrCL with area under the contrast concentrationtime curve using iodixanol[J]．Invest Radiol，2005，40(9):598-603.
|
| [26] |
Worasuwannarak S, Pornratanarangsi S．Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI：role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio[J]．J Med Assoc Thai，2010，93 (Suppl 1):S29-S34.
|
| [27] |
National Kidney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease：evaluation，classification，and stratification[J]．Am J Kidney Dis，2002，39 (2 Suppl 1):S1-S266.
|
| [28] |
杨志寅．现代医学科学发展中的缺憾与思考[J/CD]．中华诊断学电子杂志，2013，1(1):1-7.
|